Intellectual property

The generation and management of its intellectual property represent relevant value drivers for Nerviano Medical Sciences.

A core asset of a proprietary portfolio of about one hundred patent cases (totaling about 1300 active patents and patent applications) extensively covers, among others, novel and potent anticancer agents, low-molecular weight kinase inhibitors and innovativative technologies.

This portfolio is maintained by a dedicated in-house group of professionals and it is continuously enriched by filing new patent applications every year.

To give you a better browsing experience, NMS Group and Group Companies use own and third part cookies.
Browsing this web site, you allow to use them, according to our  
Cookie Policy.